193 related articles for article (PubMed ID: 7350046)
21. [Symptomatic primary biliary stenosis without cholestasis].
Velicia Llames MR; González Hernández JM; Fernández Orcajo P; Sanz Santacruz C
Gastroenterol Hepatol; 1995; 18(6):330-1. PubMed ID: 7627824
[TBL] [Abstract][Full Text] [Related]
22. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC
Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129
[TBL] [Abstract][Full Text] [Related]
23. Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy.
Horst DA; Grace ND; LeCompte PM
Gastroenterology; 1980 Sep; 79(3):550-4. PubMed ID: 7429116
[TBL] [Abstract][Full Text] [Related]
24. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
[TBL] [Abstract][Full Text] [Related]
25. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
26. [Primary biliary cirrhosis: current modes of presentation. Clinical, biochemical, immunologic and histologic study of 206 patients seen from 1978 to 1988].
Brenard R; Degos F; Degott C; Lassoued K; Benhamou JP
Gastroenterol Clin Biol; 1990; 14(4):307-12. PubMed ID: 2190853
[TBL] [Abstract][Full Text] [Related]
27. Time course of histological progression in primary biliary cirrhosis.
Locke GR; Therneau TM; Ludwig J; Dickson ER; Lindor KD
Hepatology; 1996 Jan; 23(1):52-6. PubMed ID: 8550048
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
29. [Primary biliary cirrhosis].
Brailski Kh; Damianov B
Vutr Boles; 1983; 22(5):27-37. PubMed ID: 6324495
[TBL] [Abstract][Full Text] [Related]
30. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.
Balan V; Batts KP; Porayko MK; Krom RA; Ludwig J; Wiesner RH
Hepatology; 1993 Dec; 18(6):1392-8. PubMed ID: 8244263
[TBL] [Abstract][Full Text] [Related]
31. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population.
Wong RK; Lim SG; Wee A; Chan YH; Aung MO; Wai CT
J Gastroenterol Hepatol; 2008 Apr; 23(4):599-605. PubMed ID: 17645483
[TBL] [Abstract][Full Text] [Related]
32. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity!
van Leeuwen DJ; Sood G; Ferrante D; Lazenby AJ; Sellers MJ
Semin Liver Dis; 2002 Nov; 22(4):395-406. PubMed ID: 12447711
[TBL] [Abstract][Full Text] [Related]
33. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
[TBL] [Abstract][Full Text] [Related]
35. Primary biliary cirrhosis: critical evaluation and treatment policies.
Sherlock S
Scand J Gastroenterol Suppl; 1982; 77():63-74. PubMed ID: 6750830
[TBL] [Abstract][Full Text] [Related]
36. Liver histology in benign biliary stricture: fibrosis to cirrhosis . . . and reversal?
Sikora SS; Srikanth G; Agrawal V; Gupta RK; Kumar A; Saxena R; Kapoor VK
J Gastroenterol Hepatol; 2008 Dec; 23(12):1879-84. PubMed ID: 19120875
[TBL] [Abstract][Full Text] [Related]
37. Independent prognostic factors in patients with liver cirrhosis.
Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
[TBL] [Abstract][Full Text] [Related]
38. [The prognostic factors and evolution of the quality of life in primary biliary cirrhosis].
Moreno Sánchez D; Cassinello Ogea C; Medina Asensio J; Castilla Castellano V; Castellano Tortajada G; Solís Herruzo JA
Med Clin (Barc); 1990 Oct; 95(13):490-4. PubMed ID: 2084426
[TBL] [Abstract][Full Text] [Related]
39. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
40. [Histological and clinical studies on the differential diagnosis of the aggressive chronic hepatitis and primary biliary liver cirrhosis].
Lüders CJ; Kruck P; Henning H; Look D
Z Gastroenterol; 1974 Oct; 12(6):467-84. PubMed ID: 4428821
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
